Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182
ICU Medical Inc ICUI
$168.51
▲ +0.08%
(+$0.13)
📈 Near 52W High
📅 Earnings This Week
Open
$169.32
Prev Close
$168.38
Day Range
$165.76 – $169.82
52W Range
$107.00 – $170.81
Market Cap
$4.21B
P/E (TTM)
90.07
Beta
0.75
EPS (TTM)
$1.85
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1992-03-31 |
| Shares Out. | 24,990,000 |
| Website | icumed.com/ ↗ |
| Phone | 13026365400 |
| Employees | 13,000 |
| Revenue | $530.2M |
| Gross Profit | $206.2M |
| Net Income | $30.1M |
| Free Cash Flow | $82.7M |
| Total Assets | $4.01B |
| Total Liabilities | $1.90B |
| Equity | $2.11B |
About ICU Medical Inc
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
ICU Medical Inc is a publicly traded company under the ticker symbol ICUI on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)